Intra-Cellular TherapiesITCI 
$74.70-0.55%24h
-0.55%24h
Global rank2100
Market cap$7.19B
Change 7d0.32%
YTD Performance5.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Intra-Cellular Therapies (ITCI)
As of November 2024, Intra-Cellular Therapies has a market cap of $7.19B. This makes Intra-Cellular Therapies the world's 2100th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Intra-Cellular Therapies from 2014 to 2024
-
Value:-
Market cap history of Intra-Cellular Therapies from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $7.04B | 2.21% |
| 2023 | $6.89B | 35.34% |
| 2022 | $5.09B | 1.11% |
| 2021 | $5.04B | 64.59% |
| 2020 | $3.06B | -7.32% |
| 2019 | $3.30B | 201.23% |
| 2018 | $1.10B | -21.34% |
| 2017 | $1.39B | -4.04% |
| 2016 | $1.45B | -71.95% |
| 2015 | $5.18B | 204.76% |
| 2014 | $1.70B | - |
ITCI Market Cap Today is $7.19B -0.55% - 1 Nov 2024
View largest stocks by market cap 
